Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutriearth is a French biotechnology company specializing in the development and production of high-value nutritional ingredients derived from insects, specifically the yellow mealworm (Tenebrio molitor). The company utilizes a proprietary bio-refinery process to extract natural Vitamin D3, proteins, and lipids intended for the pharmaceutical, nutraceutical, and food industries. Their flagship innovation is a natural, minimally processed Vitamin D3 that offers a sustainable alternative to traditional lanolin-based sources. Nutriearth focuses on addressing global health challenges such as Vitamin D deficiency and malnutrition through eco-responsible and circular economy practices. Based in the Hauts-de-France region, the company is positioned at the intersection of AgTech and HealthTech, providing patented solutions for human health and longevity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutriearth.